Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Castellano

Showing results (111-120 of 266) with videos related to

Pageof 27
Sort By:
Cancers|July 9, 2020
Immunohistochemistry-Based Taxonomical Classification of Bladder Cancer Predicts Response to Neoadjuvant ChemotherapyAlbert Font, Montserrat Domènech, Raquel Benítez, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|March 15, 2024
The role of PCSK9 in metabolic dysfunction-associated steatotic liver disease and its impact on bariatric surgery outcomesDaniel Castellano-Castillo, María Ángeles Núñez-Sánchez, Andrés Balaguer-Román, et al.
The Journal of Urology|April 9, 2021
Safety and Efficacy of Atezolizumab in Understudied Populations with Pretreated Urinary Tract Carcinoma: Subgroup Analyses of the SAUL Study in Real-World PracticeAxel S Merseburger, Daniel Castellano, Thomas Powles, et al.
European Urology Oncology|May 20, 2020
Pembrolizumab as First-line Therapy in Cisplatin-ineligible Advanced Urothelial Cancer (KEYNOTE-052): Outcomes in Older Patients by Age and Performance StatusPetros Grivas, Elizabeth R Plimack, Arjun V Balar, et al.
JCI Insight|November 4, 2025
Chromosomal instability in circulating tumor cells and cabazitaxel resistance in metastatic castration-resistant prostate cancerOssian Longoria, Jan Rekowski, Santosh Gupta, et al.
Oncotarget|January 7, 2017
Opposing roles of PIK3CA gene alterations to EZH2 signaling in non-muscle invasive bladder cancerCristina Segovia, Mónica Martínez-Fernández, Marta Dueñas, et al.
Cancer Medicine|April 29, 2023
Phase II study (KAMELEON) of single-agent T-DM1 in patients with HER2-positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinomaElisabeth G E de Vries, Josef Rüschoff, Martijn Lolkema, et al.
JCO Global Oncology|August 7, 2020
Survey of the Impact of COVID-19 on Oncologists' Decision Making in CancerYüksel Ürün, Syed A Hussain, Ziad Bakouny, et al.
American Journal of Cancer Research|June 9, 2023
María Santos, Javier Lanillos, Eduardo Caleiras, et al.
Investigational New Drugs|August 9, 2023
Lurbinectedin in patients with pretreated endometrial cancer: results from a phase 2 basket clinical trial and exploratory translational studyRebecca Kristeleit, Alexandra Leary, Jean Pierre Delord, et al.
Pageof 27

Showing results (111-120 of 266) with videos related to

Sort By:
Pageof 27
Cancers|July 9, 2020
Immunohistochemistry-Based Taxonomical Classification of Bladder Cancer Predicts Response to Neoadjuvant ChemotherapyAlbert Font, Montserrat Domènech, Raquel Benítez, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|March 15, 2024
The role of PCSK9 in metabolic dysfunction-associated steatotic liver disease and its impact on bariatric surgery outcomesDaniel Castellano-Castillo, María Ángeles Núñez-Sánchez, Andrés Balaguer-Román, et al.
The Journal of Urology|April 9, 2021
Safety and Efficacy of Atezolizumab in Understudied Populations with Pretreated Urinary Tract Carcinoma: Subgroup Analyses of the SAUL Study in Real-World PracticeAxel S Merseburger, Daniel Castellano, Thomas Powles, et al.
European Urology Oncology|May 20, 2020
Pembrolizumab as First-line Therapy in Cisplatin-ineligible Advanced Urothelial Cancer (KEYNOTE-052): Outcomes in Older Patients by Age and Performance StatusPetros Grivas, Elizabeth R Plimack, Arjun V Balar, et al.
JCI Insight|November 4, 2025
Chromosomal instability in circulating tumor cells and cabazitaxel resistance in metastatic castration-resistant prostate cancerOssian Longoria, Jan Rekowski, Santosh Gupta, et al.
Oncotarget|January 7, 2017
Opposing roles of PIK3CA gene alterations to EZH2 signaling in non-muscle invasive bladder cancerCristina Segovia, Mónica Martínez-Fernández, Marta Dueñas, et al.
Cancer Medicine|April 29, 2023
Phase II study (KAMELEON) of single-agent T-DM1 in patients with HER2-positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinomaElisabeth G E de Vries, Josef Rüschoff, Martijn Lolkema, et al.
JCO Global Oncology|August 7, 2020
Survey of the Impact of COVID-19 on Oncologists' Decision Making in CancerYüksel Ürün, Syed A Hussain, Ziad Bakouny, et al.
American Journal of Cancer Research|June 9, 2023
María Santos, Javier Lanillos, Eduardo Caleiras, et al.
Investigational New Drugs|August 9, 2023
Lurbinectedin in patients with pretreated endometrial cancer: results from a phase 2 basket clinical trial and exploratory translational studyRebecca Kristeleit, Alexandra Leary, Jean Pierre Delord, et al.
Pageof 27